Teva Pharmaceuticals has agreed to pay $35 million and withdraw six patents from a U.S. regulatory list to settle claims that the drugmaker delayed generic competition for its QVAR asthma inhalers, ...
Teva Pharmaceutical Industries Ltd. will pay $35 million to settle claims it delayed generic competition in the asthma inhaler market.
Amneal Pharmaceuticals (AMRX) announced that the FDA has tentatively approved the company’s abbreviated new drug application for beclomethasone ...
Beclomethasone dipropionate HFA inhalation aerosol is a corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy in patients five years of age and older. It is not ...
(NEXSTAR) – That small whoosh from an inhaler has a substantial environmental toll that could be putting some people with chronic conditions at risk, according to a new study. Published Monday in the ...
NOW THAT THE EV TAX CREDIT IS GONE, THE MILLIONS OF AMERICANS WHO STRUGGLE WITH CHRONIC LUNG DISEASE, INCLUDING ASTHMA, MAY BE ADDING TO A GLOBAL ISSUE, ACCORDING TO NEW RESEARCH. MEDICATION INHALER ...
Metered-dose inhaler propellants have contributed a rising amount to greenhouse gases in the U.S. Emissions per inhaler declined slightly over the past decade, but an increase in annual prescription ...
Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...
Amneal Pharmaceuticals, Inc. ( AMRX) Q3 2025 Earnings Call October 30, 2025 8:30 AM EDT Good morning and welcome to the Amneal Pharmaceuticals Third Quarter 2025 Earnings Call. I will now turn the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback